Literature DB >> 32807598

Metabolism-Associated Molecular Patterns (MAMPs).

Xu Wang1, Yi Wang1, Victor Antony1, Hongbin Sun2, Guang Liang3.   

Abstract

Metabolic diseases pose a tremendous health threat in both developed and developing countries. The pathophysiology of metabolic diseases is complex but has been shown to be closely associated with sterile inflammation, which is initiated by various danger molecules derived from metabolic overload, such as oxidized low-density lipoproteins (OxLDLs), free fatty acids (FFAs), glucose, advanced glycation end products (AGEs), and cholesterol. These danger signals are sensed by pattern recognition receptors (PRRs) to activate proinflammatory signaling pathways and promote the release of proinflammatory mediators, leading to chronic low-grade inflammation. Although these harmful metabolic stimuli are generally regarded as damage-associated molecular patterns (DAMPs), a more specific definition and accurate classification for these DAMPs is still missing. In this opinion, we classify the harmful metabolic stimuli that can incite inflammatory responses and tissue damage via instigating PRRs as metabolism-associated molecular patterns (MAMPs), and we summarize their roles in metaflammation-mediated metabolic diseases.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  innate immunity; metabolic disease; metabolism-associated molecular patterns; metaflammation; pattern recognition receptors

Mesh:

Substances:

Year:  2020        PMID: 32807598     DOI: 10.1016/j.tem.2020.07.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  15 in total

1.  Mechanism of protection from insulin resistance by toll-like receptor 2 deficiency in high-fat diet fed mice: involvement in macrophage polarization.

Authors:  Yu Ma; Xinyue Liu; Yaliu Wu; Wendong Wang; Xiaotong Chang
Journal:  Mol Biol Rep       Date:  2022-01-16       Impact factor: 2.316

Review 2.  The metabolic nature of inflammatory bowel diseases.

Authors:  Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-29       Impact factor: 73.082

Review 3.  TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

Authors:  Christopher R Shepard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

Review 4.  Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments.

Authors:  Cheng Peng; Alastair G Stewart; Owen L Woodman; Rebecca H Ritchie; Cheng Xue Qin
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

Review 5.  DAMPs and Innate Immune Training.

Authors:  Elisa Jentho; Sebastian Weis
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

Review 6.  Inhibitory pattern recognition receptors.

Authors:  Matevž Rumpret; Helen J von Richthofen; Victor Peperzak; Linde Meyaard
Journal:  J Exp Med       Date:  2021-12-14       Impact factor: 17.579

Review 7.  Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.

Authors:  Nicolas J Pillon; Ruth J F Loos; Sally M Marshall; Juleen R Zierath
Journal:  Cell       Date:  2021-03-05       Impact factor: 66.850

Review 8.  Modulation of endothelium function by fatty acids.

Authors:  Rahul Mallick; Asim K Duttaroy
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

9.  Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2.

Authors:  Weiwei Zhu; Namood E Sahar; Hafiz Muhammad Ahmad Javaid; Eun Seon Pak; Guang Liang; Yi Wang; Hunjoo Ha; Joo Young Huh
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

Review 10.  Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.

Authors:  Vicneswarry Dorairaj; Siti Aishah Sulaiman; Nadiah Abu; Nor Azian Abdul Murad
Journal:  Biomedicines       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.